TRIM family proteins and their emerging roles in innate immunity

[1]  L. Zakharova.  Evolution of adaptive immunity , 2009, Biology Bulletin.

[2]  C. Aiken,et al.  Proteasomal Degradation of TRIM5α during Retrovirus Restriction , 2008, PLoS pathogens.

[3]  L. James,et al.  TRIM21 is an IgG receptor that is structurally, thermodynamically, and kinetically conserved , 2008, Proceedings of the National Academy of Sciences.

[4]  K. Wada,et al.  Ubiquitination of E3 ubiquitin ligase TRIM5α and its potential role , 2008, The FEBS journal.

[5]  Weiwen Deng,et al.  TRIM30α negatively regulates TLR-mediated NF-κB activation by targeting TAB2 and TAB3 for degradation , 2008, Nature Immunology.

[6]  A. O’Garra,et al.  Type I interferon‐dependent and ‐independent expression of tripartite motif proteins in immune cells , 2008, European journal of immunology.

[7]  T. Hope,et al.  Visualization of a proteasome-independent intermediate during restriction of HIV-1 by rhesus TRIM5α , 2008, The Journal of cell biology.

[8]  A. Sher,et al.  Innate Immunity to Intraphagosomal Pathogens Is Mediated by Interferon Regulatory Factor 8 (IRF-8) That Stimulates the Expression of Macrophage-specific Nramp1 through Antagonizing Repression by c-Myc* , 2008, Journal of Biological Chemistry.

[9]  Osamu Takeuchi,et al.  MDA5/RIG-I and virus recognition. , 2008, Current opinion in immunology.

[10]  P. Uchil,et al.  TRIM E3 Ligases Interfere with Early and Late Stages of the Retroviral Life Cycle , 2008, PLoS pathogens.

[11]  F. Bushman,et al.  The Interferon Response Inhibits HIV Particle Production by Induction of TRIM22 , 2008, PLoS pathogens.

[12]  M. Massiah,et al.  Structure of the MID1 tandem B-boxes reveals an interaction reminiscent of intermolecular ring heterodimers. , 2008, Biochemistry.

[13]  J. Lieberman,et al.  Identification of Host Proteins Required for HIV Infection Through a Functional Genomic Screen , 2007, Science.

[14]  R. Higgs,et al.  The E3 Ubiquitin Ligase Ro52 Negatively Regulates IFN- Production Post-Pathogen Recognition by Polyubiquitin-Mediated Degradation of IRF3 , 2008 .

[15]  J. Sodroski,et al.  Functional Interplay Between the B-box 2 and the B30.2(SPRY) Domains of TRIM5 α , 2008 .

[16]  V. Kuchroo,et al.  Interferon-α Induces Up-regulation and Nuclear Translocation of the Ro52 Autoantigen as Detected by a Panel of Novel Ro52-specific Monoclonal Antibodies , 2008, Journal of Clinical Immunology.

[17]  Ming-Ming Zhou,et al.  PHD domain-mediated E3 ligase activity directs intramolecular sumoylation of an adjacent bromodomain required for gene silencing. , 2007, Molecular cell.

[18]  T. Imaizumi,et al.  Negative Feedback Regulation of RIG-I-Mediated Antiviral Signaling by Interferon-Induced ISG15 Conjugation , 2007, Journal of Virology.

[19]  Rosa Bernardi,et al.  Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies , 2007, Nature Reviews Molecular Cell Biology.

[20]  Michael Emerman,et al.  Discordant Evolution of the Adjacent Antiretroviral Genes TRIM22 and TRIM5 in Mammals , 2007, PLoS pathogens.

[21]  J. Qu,et al.  Nitric Oxide Destabilizes Pias3 and Regulates Sumoylation , 2007, PloS one.

[22]  S. Goff,et al.  TRIM28 Mediates Primer Binding Site-Targeted Silencing of Murine Leukemia Virus in Embryonic Cells , 2007, Cell.

[23]  K. Ozato,et al.  The role of the interferon regulatory factor (IRF) family in dendritic cell development and function. , 2007, Cytokine & growth factor reviews.

[24]  Osamu Takeuchi,et al.  Genetic analysis of resistance to viral infection , 2007, Nature Reviews Immunology.

[25]  M. Yoneyama,et al.  RIG-I family RNA helicases: cytoplasmic sensor for antiviral innate immunity. , 2007, Cytokine & growth factor reviews.

[26]  T. Schaller,et al.  An Active TRIM5 Protein in Rabbits Indicates a Common Antiviral Ancestor for Mammalian TRIM5 Proteins , 2007, Journal of Virology.

[27]  Lucia Gabriele,et al.  The feedback phase of type I interferon induction in dendritic cells requires interferon regulatory factor 8. , 2007, Immunity.

[28]  S. Pestka.  The Interferons: 50 Years after Their Discovery, There Is Much More to Learn* , 2007, Journal of Biological Chemistry.

[29]  Hyun Kook Cho,et al.  Cutting Edge: Autoantigen Ro52 Is an Interferon Inducible E3 Ligase That Ubiquitinates IRF-8 and Enhances Cytokine Expression in Macrophages1 , 2007, The Journal of Immunology.

[30]  G. Towers.  The control of viral infection by tripartite motif proteins and cyclophilin A , 2007, Retrovirology.

[31]  R. Everett,et al.  PML and PML nuclear bodies: implications in antiviral defence. , 2007, Biochimie.

[32]  A. Bowie,et al.  The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling , 2007, Nature Reviews Immunology.

[33]  Y. Ikeda,et al.  Rhesus monkey TRIM5α restricts HIV-1 production through rapid degradation of viral Gag polyproteins , 2007, Nature Medicine.

[34]  Osamu Takeuchi,et al.  TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity , 2007, Nature.

[35]  J. Trowsdale,et al.  Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein function , 2007, Proceedings of the National Academy of Sciences.

[36]  O. Pybus,et al.  Discovery and analysis of the first endogenous lentivirus , 2007, Proceedings of the National Academy of Sciences.

[37]  Dong-er Zhang,et al.  Negative regulation of ISG15 E3 ligase EFP through its autoISGylation. , 2007, Biochemical and biophysical research communications.

[38]  A. Sher,et al.  Cooperation of Toll-like receptor signals in innate immune defence , 2007, Nature Reviews Immunology.

[39]  P. Tailor,et al.  Interferon Regulatory Factor-8 Is Indispensable for the Expression of Promyelocytic Leukemia and the Formation of Nuclear Bodies in Myeloid Cells* , 2007, Journal of Biological Chemistry.

[40]  D. Chitayat,et al.  MID1 mutation screening in a large cohort of Opitz G/BBB syndrome patients: twenty‐nine novel mutations identified , 2007, Human mutation.

[41]  F. Papavasiliou,et al.  Beyond SHM and CSR: AID and related cytidine deaminases in the host response to viral infection. , 2007, Advances in immunology.

[42]  B. Oh,et al.  Structural basis for protein recognition by B30.2/SPRY domains. , 2006, Molecular cell.

[43]  K. Horie-Inoue,et al.  A ubiquitin E3 ligase Efp is up-regulated by interferons and conjugated with ISG15. , 2006, Biochemical and biophysical research communications.

[44]  R. Lu,et al.  IFN Regulatory Factor 4 and 8 Promote Ig Light Chain κ Locus Activation in Pre-B Cell Development1 , 2006, The Journal of Immunology.

[45]  Alberto Mantovani,et al.  Transcriptional Profiling of the Human Monocyte-to-Macrophage Differentiation and Polarization: New Molecules and Patterns of Gene Expression1 , 2006, The Journal of Immunology.

[46]  J. Sodroski,et al.  Characterization of TRIM5alpha trimerization and its contribution to human immunodeficiency virus capsid binding. , 2006, Virology.

[47]  Hideaki Ishikawa,et al.  TRIM11 binds to and destabilizes a key component of the activator‐mediated cofactor complex (ARC105) through the ubiquitin–proteasome system , 2006, FEBS letters.

[48]  G. Stark,et al.  Complex modulation of cell type-specific signaling in response to type I interferons. , 2006, Immunity.

[49]  Y. Percherancier,et al.  Cross Talk between PML and p53 during Poliovirus Infection: Implications for Antiviral Defense , 2006, Journal of Virology.

[50]  Amalio Telenti,et al.  Role of common human TRIM5α variants in HIV-1 disease progression , 2006, Retrovirology.

[51]  Andrea Michael Meyer,et al.  Regulation of p27 Degradation and S-Phase Progression by Ro52 RING Finger Protein , 2006, Molecular and Cellular Biology.

[52]  R. Everett,et al.  PML Contributes to a Cellular Mechanism of Repression of Herpes Simplex Virus Type 1 Infection That Is Inactivated by ICP0 , 2006, Journal of Virology.

[53]  P. Pandolfi,et al.  A CK2-Dependent Mechanism for Degradation of the PML Tumor Suppressor , 2006, Cell.

[54]  J. Sodroski,et al.  Functional Replacement of the RING, B-Box 2, and Coiled-Coil Domains of Tripartite Motif 5α (TRIM5α) by Heterologous TRIM Domains , 2006, Journal of Virology.

[55]  J. Sodroski,et al.  Rapid turnover and polyubiquitylation of the retroviral restriction factor TRIM5. , 2006, Virology.

[56]  T. Hope,et al.  Proteasome inhibitors uncouple rhesus TRIM5alpha restriction of HIV-1 reverse transcription and infection. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[57]  A. Engelman,et al.  Evolution of a cytoplasmic tripartite motif (TRIM) protein in cows that restricts retroviral infection. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[58]  T. Cox,et al.  Subclassification of the RBCC/TRIM Superfamily Reveals a Novel Motif Necessary for Microtubule Binding* , 2006, Journal of Biological Chemistry.

[59]  K. Wada,et al.  UnpEL/Usp4 is ubiquitinated by Ro52 and deubiquitinated by itself. , 2006, Biochemical and biophysical research communications.

[60]  M. El-Khateeb,et al.  Familial Mediterranean fever in Arabs , 2006, The Lancet.

[61]  Dong-er Zhang,et al.  The Interferon-inducible Ubiquitin-protein Isopeptide Ligase (E3) EFP Also Functions as an ISG15 E3 Ligase* , 2006, Journal of Biological Chemistry.

[62]  P. Lipsky,et al.  Regulation of the germinal center gene program by interferon (IFN) regulatory factor 8/IFN consensus sequence-binding protein , 2006, The Journal of experimental medicine.

[63]  Z. Zhai,et al.  The Ret Finger Protein Inhibits Signaling Mediated by the Noncanonical and Canonical IκB Kinase Family Members1 , 2006, The Journal of Immunology.

[64]  J. Tschopp,et al.  Structure of the PRYSPRY‐domain: Implications for autoinflammatory diseases , 2006, FEBS letters.

[65]  浅岡 健太郎.  A retrovirus restriction factor TRIM5α is transcriptionally regulated by interferons , 2006 .

[66]  S. Akira,et al.  TLR signaling. , 2006, Current topics in microbiology and immunology.

[67]  J. Opitz,et al.  An Xq22.3 duplication detected by comparative genomic hybridization microarray (Array‐CGH) defines a new locus (FGS5) for FG syndrome , 2005, American journal of medical genetics. Part A.

[68]  K. Nagata,et al.  Serum-dependent expression of promyelocytic leukemia protein suppresses propagation of influenza virus. , 2005, Virology.

[69]  B. de Bono,et al.  Relationship between SPRY and B30.2 protein domains. Evolution of a component of immune defence? , 2005, Immunology.

[70]  J. Sodroski,et al.  Retroviral Restriction Factor TRIM5α Is a Trimer , 2005, Journal of Virology.

[71]  Ki-Young Lee,et al.  TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. , 2005, Genes & development.

[72]  G. Comi,et al.  Molecular etiopathogenesis of limb girdle muscular and congenital muscular dystrophies: boundaries and contiguities. , 2005, Clinica chimica acta; international journal of clinical chemistry.

[73]  G. Meroni,et al.  TRIM/RBCC, a novel class of ‘single protein RING finger’ E3 ubiquitin ligases , 2005, BioEssays : news and reviews in molecular, cellular and developmental biology.

[74]  S. Nisole,et al.  TRIM family proteins: retroviral restriction and antiviral defence , 2005, Nature Reviews Microbiology.

[75]  D. Kastner,et al.  Familial autoinflammatory diseases: genetics, pathogenesis and treatment , 2005, Current opinion in rheumatology.

[76]  Masahide Takahashi,et al.  PIAS proteins are involved in the SUMO-1 modification, intracellular translocation and transcriptional repressive activity of RET finger protein. , 2005, Experimental cell research.

[77]  K. Shuai,et al.  Regulation of gene-activation pathways by PIAS proteins in the immune system , 2005, Nature Reviews Immunology.

[78]  K. Ozato,et al.  Ubiquitin-dependent Degradation of Interferon Regulatory Factor-8 Mediated by Cbl Down-regulates Interleukin-12 Expression* , 2005, Journal of Biological Chemistry.

[79]  J. Luban,et al.  TRIM5α selectively binds a restriction-sensitive retroviral capsid , 2005, Retrovirology.

[80]  W. Sellers,et al.  Selective ablation of retinoblastoma protein function by the RET finger protein. , 2005, Molecular cell.

[81]  J. O’Shea,et al.  IFN Regulatory Factor-4 and -8 Govern Dendritic Cell Subset Development and Their Functional Diversity , 2005, The Journal of Immunology.

[82]  Jonathan P. Stoye,et al.  A Single Amino Acid Change in the SPRY Domain of Human Trim5α Leads to HIV-1 Restriction , 2005, Current Biology.

[83]  G. Trinchieri,et al.  Production of type I interferons: plasmacytoid dendritic cells and beyond , 2005 .

[84]  M. Flajnik,et al.  Evolution of innate and adaptive immunity: can we draw a line? , 2004, Trends in immunology.

[85]  S. Goff.  Genetic control of retrovirus susceptibility in mammalian cells. , 2004, Annual review of genetics.

[86]  S. Nisole,et al.  Trim5α protein restricts both HIV-1 and murine leukemia virus , 2004 .

[87]  A. Reiter,et al.  Pathogenesis, Diagnosis and Monitoring of Residual Disease in Acute Promyelocytic Leukaemia , 2004, Acta Haematologica.

[88]  C. M. Owens,et al.  The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys , 2004, Nature.

[89]  G. Lozano,et al.  RING protein Trim32 associated with skin carcinogenesis has anti-apoptotic and E3-ubiquitin ligase properties. , 2003, Carcinogenesis.

[90]  Masahide Takahashi,et al.  Mi-2β Associates with BRG1 and RET Finger Protein at the Distinct Regions with Transcriptional Activating and Repressing Abilities* , 2003, Journal of Biological Chemistry.

[91]  C. Kedinger,et al.  Adenovirus protein IX sequesters host‐cell promyelocytic leukaemia protein and contributes to efficient viral proliferation , 2003, EMBO reports.

[92]  Y. Shimizu-Yoshida,et al.  Novel tumorigenic rearrangement, Delta rfp/ret, in a papillary thyroid carcinoma from externally irradiated patient. , 2003, Mutation research.

[93]  S. Schweiger,et al.  The MID1/PP2A complex: a key to the pathogenesis of Opitz BBB/G syndrome. , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.

[94]  S. Iwata,et al.  SS-A/Ro52, an Autoantigen Involved in CD28-Mediated IL-2 Production 1 , 2003, The Journal of Immunology.

[95]  I. Nishimoto,et al.  A tripartite motif protein TRIM11 binds and destabilizes Humanin, a neuroprotective peptide against Alzheimer's disease‐relevant insults , 2003, The European journal of neuroscience.

[96]  P. Rothman,et al.  TRIM8/GERP RING Finger Protein Interacts with SOCS-1* , 2002, The Journal of Biological Chemistry.

[97]  Satoshi Inoue,et al.  Efp targets 14-3-3σ for proteolysis and promotes breast tumour growth , 2002, Nature.

[98]  A. Brice,et al.  MID1, mutated in Opitz syndrome, encodes a ubiquitin ligase that targets phosphatase 2A for degradation , 2002, Nature Genetics.

[99]  Y. Ben-Neriah.  Regulatory functions of ubiquitination in the immune system , 2002, Nature Immunology.

[100]  P. Freemont,et al.  PML protein isoforms and the RBCC/TRIM motif , 2001, Oncogene.

[101]  D J Glass,et al.  Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy , 2001, Science.

[102]  A. Capron,et al.  SS-56, a novel cellular target of autoantibody responses in Sjögren syndrome and systemic lupus erythematosus. , 2001, The Journal of clinical investigation.

[103]  P. Pandolfi,et al.  PML mediates the interferon‐induced antiviral state against a complex retrovirus via its association with the viral transactivator , 2001, The EMBO journal.

[104]  Paul Freemont,et al.  Role of Promyelocytic Leukemia (Pml) Sumolation in Nuclear Body Formation, 11s Proteasome Recruitment, and as2O3-Induced Pml or Pml/Retinoic Acid Receptor α Degradation , 2001, The Journal of experimental medicine.

[105]  Alessandro Guffanti,et al.  The tripartite motif family identifies cell compartments , 2001, The EMBO journal.

[106]  L. Etkin,et al.  Two B or not two B? Overview of the rapidly expanding B-box family of proteins. , 2001, Differentiation; research in biological diversity.

[107]  S. Minucci,et al.  Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation. , 2000, Molecular cell.

[108]  P. Pandolfi,et al.  Role of SUMO-1-modified PML in nuclear body formation. , 2000, Blood.

[109]  C Caux,et al.  Immunobiology of dendritic cells. , 2000, Annual review of immunology.

[110]  T. Hunter,et al.  The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. , 1999, Science.

[111]  S. Fang,et al.  RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[112]  Y. Yarden,et al.  The RING Finger of c-Cbl Mediates Desensitization of the Epidermal Growth Factor Receptor* , 1999, The Journal of Biological Chemistry.

[113]  H. Rabes,et al.  The transcription coactivator HTIF1 and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomas , 1999, Oncogene.

[114]  G. Stark,et al.  How cells respond to interferons. , 1998, Annual review of biochemistry.

[115]  C. Disteche,et al.  The mouse Mid1 gene: implications for the pathogenesis of Opitz syndrome and the evolution of the mammalian pseudoautosomal region. , 1998, Human molecular genetics.

[116]  F. Collins,et al.  Ancient Missense Mutations in a New Member of the RoRet Gene Family Are Likely to Cause Familial Mediterranean Fever , 1997, Cell.

[117]  P. Chambon,et al.  TIF I α: chromatin-specific mediator for the ligand-dependent activation function AF-2 of nuclear receptors? , 1997 .

[118]  U. Boehm,et al.  Cellular responses to interferon-gamma. , 1997, Annual review of immunology.

[119]  Jonathan P. Stoye,et al.  Positional cloning of the mouse retrovirus restriction gene Fvl , 1996, Nature.

[120]  D. Speicher,et al.  KAP-1, a novel corepressor for the highly conserved KRAB repression domain. , 1996, Genes & development.

[121]  M. Katze,et al.  Interferon treatment inhibits virus replication in HIV-1- and SIV-infected CD4+ T-cell lines by distinct mechanisms: evidence for decreased stability and aberrant processing of HIV-1 proteins. , 1995, Virology.

[122]  N. Mechti,et al.  Molecular Cloning of a New Interferon-induced Factor That Represses Human Immunodeficiency Virus Type 1 Long Terminal Repeat Expression (*) , 1995, The Journal of Biological Chemistry.

[123]  B. Cullen,et al.  Identification of a novel human zinc finger protein that specifically interacts with the activation domain of lentiviral Tat proteins. , 1995, Virology.

[124]  A. Fauci,et al.  Alpha interferon suppresses virion but not soluble human immunodeficiency virus antigen production in chronically infected T-lymphocytic cells , 1991, Journal of virology.

[125]  K. Sullivan,et al.  A 52-kD protein is a novel component of the SS-A/Ro antigenic particle , 1988, The Journal of experimental medicine.